P

Inventor

OLIVER AMY

US36 patents
⚠️ This page may combine multiple inventors who share the name “OLIVER AMY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ICOS CORP

28 patents
US7932260B2Apr 26, 2011

Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta

ICOS CORP221 citations99
US6949535B2Sep 27, 2005

Inhibitors of human phosphatidyl-inositol 3-kinase delta

ICOS CORP172 citations99
US6667300B2Dec 23, 2003

Inhibitors of human phosphatidylinositol 3-kinase delta

ICOS CORP174 citations99
US6518277B1Feb 11, 2003

Inhibitors of human phosphatidylinositol 3-kinase delta

ICOS CORP272 citations99
US8980901B2Mar 17, 2015

5-fluoro-3-phenyl-2[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta

ICOS CORP39 citations98
US8586597B2Nov 19, 2013

6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta

ICOS CORP36 citations98
USRE44599ENov 12, 2013

Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta

ICOS CORP44 citations98
US9487772B2Nov 8, 2016

Inhibitors of human phosphatidylinositol 3-kinase delta

ICOS CORP19 citations96
US8993583B2Mar 31, 2015

5-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta

ICOS CORP22 citations96
US8779131B2Jul 15, 2014

6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta

ICOS CORP30 citations96
US6348602B1Feb 19, 2002

Cyclic AMP-specific phosphodiesterase inhibitors

ICOS CORP49 citations96
US6423710B1Jul 23, 2002

Cyclic AMP-specific phosphodiesterase inhibitors

ICOS CORP47 citations95
US6258833B1Jul 10, 2001

Cyclic AMP-specific phosphodiesterase inhibitors

ICOS CORP55 citations94
US10010550B2Jul 3, 2018

Inhibitors of human phosphatidylinositol 3-kinase delta

ICOS CORP11 citations92
US9149477B2Oct 6, 2015

5-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta

ICOS CORP17 citations92
US6716871B2Apr 6, 2004

Cyclic AMP-specific phosphodie sterase inhibitors

ICOS CORP14 citations92
US6500856B2Dec 31, 2002

Cyclic AMP-specific phosphodiesterase inhibitors

ICOS CORP20 citations92
US6569885B1May 27, 2003

Cyclic AMP-specific phosphodiesterase inhibitors

ICOS CORP18 citations91
US6569890B2May 27, 2003

Cyclic AMP-specific phosphodiesterase inhibitors

ICOS CORP19 citations91
US6458787B1Oct 1, 2002

Cyclic AMP-specific phosphodiesterase inhibitors

ICOS CORP24 citations91
US6372777B1Apr 16, 2002

Cyclic AMP-specific phosphodiesterase inhibitors

ICOS CORP36 citations91
US10695349B2Jun 30, 2020

Inhibitors of human phosphatidylinositol 3-kinase delta

ICOS CORP2 citations84
US10398695B2Sep 3, 2019

Inhibitors of human phosphatidylinositol 3-kinase delta

ICOS CORP5 citations84
US10336756B2Jul 2, 2019

(S)-2-(1-aminopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one precursor of a quinazolinone as inhibitor of human phosphatidylinositol 3-kinase delta

ICOS CORP5 citations84
US10906907B2Feb 2, 2021

Tert-butyl (s)-(1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbamate precursor of a quinazolinone inhibitor of human phosphatidylinositol 3-kinase delta and a process for preparing thereof

ICOS CORP0 citations73
US6998416B2Feb 14, 2006

Cyclic AMP-specific phosphodiesterase inhibitors

ICOS CORP1 citations62
US7176229B2Feb 13, 2007

Cyclic AMP-specific phosphodiesterase inhibitors

ICOS CORP0 citations51
US7087634B2Aug 8, 2006

Cyclic AMP-specific phosphodiesterase inhibitors

ICOS CORP0 citations51

SADHU CHANCHAL

5 patents

FOWLER KERRY W

2 patents

ICOS

1 patent